Document is current

Any future updates will be listed below

Neoadjuvant sunitinib plus exemestane in post-menopausal women with hormone receptor-positive/HER2-negative early-stage breast cancer (SUT_EXE-08): a phase I/II trial

Crossref DOI link: https://doi.org/10.1038/s41598-024-72152-1

Published Online: 2024-10-09

Update policy: https://doi.org/10.1007/springer_crossmark_policy

About CrossMark